{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T17:43:22Z","timestamp":1751996602600,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Intramural Research Program of the U.S. National Cancer Institute"},{"name":"Huntsman Cancer Institute\/Huntsman Cancer Foundation"},{"name":"Nordic Cancer Union"},{"name":"Swedish Cancer Society","award":["CAN 2016\/440"],"award-info":[{"award-number":["CAN 2016\/440"]}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10552-023-01832-6","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T03:21:07Z","timestamp":1703215267000},"page":"741-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case\u2013control study"],"prefix":"10.1007","volume":"35","author":[{"given":"Jazmine","family":"Abril","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-6090","authenticated-orcid":false,"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Grotmol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Ekbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Madanat-Harjuoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Gulbech Ording","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steinar","family":"Tretli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tone","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"issue":"1","key":"1832_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","volume":"116","author":"E D\u2019Angelo","year":"2010","unstructured":"D\u2019Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131\u2013139. https:\/\/doi.org\/10.1016\/j.ygyno.2009.09.023","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1832_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","volume":"104","author":"J Prat","year":"2009","unstructured":"Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynecol Obstet 104(3):177\u2013178. https:\/\/doi.org\/10.1016\/j.ijgo.2008.12.008","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cncr.11484","volume":"98","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Devesa SS (2003) Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98(1):176\u2013186. https:\/\/doi.org\/10.1002\/cncr.11484","journal-title":"Cancer"},{"issue":"6","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","volume":"8","author":"MA Clarke","year":"2022","unstructured":"Clarke MA, Devesa SS, Hammer A, Wentzensen N (2022) Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by Stage and histologic subtype. JAMA Oncol 8(6):895\u2013903. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0009","journal-title":"JAMA Oncol"},{"issue":"3","key":"1832_CR5","first-page":"399","volume":"76","author":"BL Harlow","year":"1986","unstructured":"Harlow BL, Weiss NS, Lofton S (1986) The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76(3):399\u2013402","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1832_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/bjc.2013.2","volume":"108","author":"AS Felix","year":"2013","unstructured":"Felix AS, Cook LS, Gaudet MM et al (2013) The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 108(3):727\u2013734. https:\/\/doi.org\/10.1038\/bjc.2013.2","journal-title":"Br J Cancer"},{"issue":"12","key":"1832_CR7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/1097-0142(19891215)64:12<2487::AID-CNCR2820641214>3.0.CO;2-K","volume":"64","author":"SM Schwartz","year":"1989","unstructured":"Schwartz SM, Thomas DB (1989) A case\u2014control study of risk factors for sarcomas of the uterus: the World Health Organization Collaborative study of neoplasia and steroid contraceptives. Cancer 64(12):2487\u20132492.","journal-title":"Cancer"},{"key":"1832_CR8","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.ijgo.2015.06.006","volume":"131","author":"J Prat","year":"2015","unstructured":"Prat J (2015) Mbatani \u2019nomonde. uterine sarcomas. Int J Gynecol Obstet 131:S105\u2013S110. https:\/\/doi.org\/10.1016\/j.ijgo.2015.06.006","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1525-1438.2002.01151.x","volume":"12","author":"WG McCluggage","year":"2002","unstructured":"McCluggage WG (2002) Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12(6):687\u2013690. https:\/\/doi.org\/10.1046\/j.1525-1438.2002.01151.x","journal-title":"Int J Gynecol Cancer"},{"key":"1832_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/IJWH.S117754","volume":"9","author":"C Benson","year":"2017","unstructured":"Benson C, Miah AB (2017) Uterine sarcoma\u2013current perspectives. Int J Womens Health 9:597\u2013606. https:\/\/doi.org\/10.2147\/IJWH.S117754","journal-title":"Int J Womens Health"},{"issue":"6","key":"1832_CR11","first-page":"1886","volume":"50","author":"SM Schwartz","year":"1990","unstructured":"Schwartz SM, Weiss NS (1990) Marital status and the incidence of sarcomas of the uterus. Cancer Res 50(6):1886\u20131889","journal-title":"Cancer Res"},{"issue":"2","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1525-1438.2007.01025.x","volume":"18","author":"O Lavie","year":"2008","unstructured":"Lavie O, Barnett-Griness O, Narod Sa, Rennert G (2008) The risk of developing uterine sarcoma after tamoxifen use. Int J Gynecol Cancer 18(2):352\u2013356. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01025.x","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"1832_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ygyno.2011.04.003","volume":"122","author":"S Jaakkola","year":"2011","unstructured":"Jaakkola S, Lyytinen HK, Pukkala E, Ylikorkala O (2011) Use of estradiol\u2013progestin therapy associates with increased risk for uterine sarcomas. Gynecol Oncol 122(2):260\u2013263. https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.003","journal-title":"Gynecol Oncol"},{"issue":"21","key":"1832_CR14","first-page":"6217","volume":"48","author":"G Kv\u00e5le","year":"1988","unstructured":"Kv\u00e5le G, Heuch I, Ursin G (1988) Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res 48(21):6217\u20136221","journal-title":"Cancer Res"},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","volume":"13","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Ludvigsson JF, Schmidt M et al (2021) Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol 13:533\u2013555. https:\/\/doi.org\/10.2147\/CLEP.S314959","journal-title":"Clin Epidemiol"},{"issue":"8","key":"1832_CR16","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/ijc.31600","volume":"143","author":"R Troisi","year":"2018","unstructured":"Troisi R, Gulbech Ording A, Grotmol T et al (2018) Pregnancy complications and subsequent breast cancer risk in the mother: a nordic population-based case\u2013control study. Int J Cancer 143(8):1904\u20131913. https:\/\/doi.org\/10.1002\/ijc.31600","journal-title":"Int J Cancer"},{"issue":"11","key":"1832_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/bjc.2016.315","volume":"115","author":"T Bj\u00f8rge","year":"2016","unstructured":"Bj\u00f8rge T, Gissler M, Ording AG et al (2016) Reproductive history and risk of colorectal adenocarcinoma in parous women: a nordic population-based case\u2013control study. Br J Cancer 115(11):1416\u20131420. https:\/\/doi.org\/10.1038\/bjc.2016.315","journal-title":"Br J Cancer"},{"issue":"5","key":"1832_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/joim.12747","volume":"283","author":"R Troisi","year":"2018","unstructured":"Troisi R, Bj\u00f8rge T, Gissler M et al (2018) The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med 283(5):430\u2013445. https:\/\/doi.org\/10.1111\/joim.12747","journal-title":"J Intern Med"},{"issue":"8","key":"1832_CR19","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ijc.31581","volume":"143","author":"C Sk\u00f6ld","year":"2018","unstructured":"Sk\u00f6ld C, Bj\u00f8rge T, Ekbom A et al (2018) Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. Int J Cancer 143(8):1858\u20131867. https:\/\/doi.org\/10.1002\/ijc.31581","journal-title":"Int J Cancer"},{"issue":"6","key":"1832_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/ijc.32494","volume":"146","author":"B Trabert","year":"2020","unstructured":"Trabert B, Troisi R, Grotmol T et al (2020) Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: a nordic population-based case\u2013control study. Int J Cancer 146(6):1523\u20131531. https:\/\/doi.org\/10.1002\/ijc.32494","journal-title":"Int J Cancer"},{"issue":"1","key":"1832_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow L, Westergren K, Holmberg L, Talb\u00e4ck M (2009) The completeness of the Swedish cancer register\u2013a sample survey for year 1998. Acta Oncol 48(1):27\u201333. https:\/\/doi.org\/10.1080\/02841860802247664","journal-title":"Acta Oncol"},{"issue":"7suppl","key":"1832_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML (2011) The danish cancer registry. Scand J Public Health 39(7suppl):42\u201345. https:\/\/doi.org\/10.1177\/1403494810393562","journal-title":"Scand J Public Health"},{"issue":"7","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, Sm\u00e5stuen M, Johannesen TB et al (2009) Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45(7):1218\u20131231. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.037","journal-title":"Eur J Cancer"},{"key":"1832_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","volume":"77","author":"MK Leinonen","year":"2017","unstructured":"Leinonen MK, Miettinen J, Heikkinen S, Pitk\u00e4niemi J, Malila N (2017) Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer 77:31\u201339. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.017","journal-title":"Eur J Cancer"},{"key":"1832_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449\u2013490. https:\/\/doi.org\/10.2147\/CLEP.S91125","journal-title":"Clin Epidemiol"},{"issue":"20","key":"1832_CR26","doi-asserted-by":"publisher","first-page":"11202","DOI":"10.3390\/ijms222011202","volume":"22","author":"K Hong","year":"2021","unstructured":"Hong K, Kim SH, Cha DH, Park HJ (2021) Defective uteroplacental vascular remodeling in preeclampsia: key molecular factors leading to long term cardiovascular disease. Int J Mol Sci 22(20):11202. https:\/\/doi.org\/10.3390\/ijms222011202","journal-title":"Int J Mol Sci"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01832-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T09:24:18Z","timestamp":1714037058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01832-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"We obtained approval for this study from Ethics Committees in Norway and Sweden, from the Data Protection Agency in Denmark, and from the Finnish Institute for Health and Welfare in Finland after consulting its Data Protection Authority.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}